Diamox Sequels Interactions
There are 262 drugs known to interact with Diamox Sequels (acetazolamide), along with 12 disease interactions. Of the total drug interactions, 23 are major, 222 are moderate, and 17 are minor.
- View all 262 medications that may interact with Diamox Sequels
- View Diamox Sequels disease interactions (12)
Most frequently checked interactions
View interaction reports for Diamox Sequels (acetazolamide) and the medicines listed below.
- Adderall XR (amphetamine / dextroamphetamine)
- Aimovig (erenumab)
- albuterol
- Benadryl (diphenhydramine)
- biotin
- Cymbalta (duloxetine)
- doxycycline
- Effexor XR (venlafaxine)
- Flexeril (cyclobenzaprine)
- gabapentin
- Lamictal (lamotrigine)
- Lasix (furosemide)
- Lexapro (escitalopram)
- Lyrica (pregabalin)
- metformin
- nortriptyline
- omeprazole
- oxycodone
- Prilosec (omeprazole)
- Singulair (montelukast)
- spironolactone
- Synthroid (levothyroxine)
- Topamax (topiramate)
- topiramate
- tramadol
- verapamil
- Vitamin B12 (cyanocobalamin)
- Vitamin C (ascorbic acid)
- Vitamin D3 (cholecalciferol)
- Zofran (ondansetron)
Diamox Sequels disease interactions
There are 12 disease interactions with Diamox Sequels (acetazolamide) which include:
- bone marrow depression/blood dyscrasias
- adrenal insufficiency
- closed-angle glaucoma
- hypokalemia
- hyponatremia
- severe kidney disease
- severe liver disease
- respiratory acidosis
- renal dysfunction
- diabetes mellitus
- gout
- metabolic acidosis
Report options
QR code containing a link to this page
More about Diamox Sequels (acetazolamide)
- Diamox Sequels consumer information
- Check interactions
- Compare alternatives
- Reviews (6)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: carbonic anhydrase inhibitor anticonvulsants
- Breastfeeding
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
